Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

179 та иш

Иш: Exploring Potential Mechanisms for Epilepsy After <scp>mRNA COVID</scp> ‐19 Vaccination: An Extremely Rare Side‐Effect

  1. Extrapulmonary manifestations of COVID-19

    Aakriti Gupta, Mahesh V. Madhavan, Kartik Sehgal +26

    Шарҳ мақола20205 иқтибос
    ABI

  2. Decoding virulence and resistance in Klebsiella pneumoniae: Pharmacological insights, immunological dynamics, and in silico therapeutic strategies

    Ali Alishvandi, Maryam Barancheshemeh, Faezeh Firuzpour +3

    Шарҳ мақола20255 иқтибос
    ABI

  3. Development of a candidate mRNA vaccine based on Multi-Peptide targeting VP4 of rotavirus A: an immunoinformatics and molecular dynamics approach

    Cena Aram, Leila Karami, Mohammad Mehdi Ranjbar

    Мақола20255 иқтибос
    ABI

  4. Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats

    Yutao Lou, Feifeng Song, Mengting Cheng +8

    Мақола20234 иқтибос
    ABI

  5. Nanocarriers in glioblastoma treatment: a neuroimmunological perspective

    Faezeh Firuzpour, Kiarash Saleki, Cena Aram +1

    Шарҳ мақола20244 иқтибос
    ABI

  6. Clinical and immunological features of severe and moderate coronavirus disease 2019

    Guang Chen, Di Wu, Wei Guo +17

    Мақола20203 иқтибос
    ABI

  7. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement

    Rumiana Tenchov, Robert E. Bird, Allison Curtze +1

    Шарҳ мақола20213 иқтибос
    ABI

  8. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy

    Annamaria Vezzani, Silvia Balosso, Teresa Ravizza

    Шарҳ мақола20193 иқтибос
    ABI

  9. Meningitis after COVID-19 vaccination, a systematic review of case reports and case series

    Amirhomayoun Atefi, Aref Ghanaatpisheh, Amirhosein Ghasemi +6

    Шарҳ мақола20243 иқтибос
    ABI

  10. mRNA vaccines for infectious diseases: principles, delivery and clinical translation

    Namit Chaudhary, Drew Weissman, Kathryn A. Whitehead

    Шарҳ мақола20213 иқтибос
    ABI

  11. IL-6 in Inflammation, Immunity, and Disease

    Toshio Tanaka, Masashi Narazaki, T Kishimoto

    Шарҳ мақола20143 иқтибос
    ABI

  12. SARS-CoV-2 viral load is associated with increased disease severity and mortality

    Jesse Fajnzylber, James Regan, Kendyll Coxen +97

    Мақола20202 иқтибос
    ABI

  13. Development and validation of an automatic machine learning model to predict abnormal increase of transaminase in valproic acid-treated epilepsy

    Hongying Ma, Sihui Huang, Fengxin Li +7

    Мақола20242 иқтибос
    ABI

  14. Evolution of antibody immunity to SARS-CoV-2

    Christian Gaebler, Zijun Wang, Julio C. C. Lorenzi +39

    Мақола20212 иқтибос
    ABI

  15. Direct Gene Transfer into Mouse Muscle in Vivo

    Jon A. Wolff, Robert W. Malone, Phillip Williams +4

    Мақола19902 иқтибос
    ABI

  16. Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and Excitotoxicity

    Gabriel Olmos, Jerònia Lladó

    Шарҳ мақола20142 иқтибос
    ABI

  17. Multiple Sclerosis Pathology

    Hans Lassmann

    Шарҳ мақола20182 иқтибос
    ABI

  18. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

    David Adams, Alejandra González‐Duarte, William O’Riordan +33

    Мақола20182 иқтибос
    ABI

  19. Detection of SARS-CoV-2 in Different Types of Clinical Specimens

    Wenling Wang, Yanli Xu, Ruqin Gao +4

    Мақола20202 иқтибос
    ABI

  20. Virological assessment of hospitalized patients with COVID-2019

    Roman Wölfel, Victor M. Corman, Wolfgang Guggemos +15

    Мақола20202 иқтибос
    ABI

  21. Acidity enhancement of α‐carbon of beta diketones via hydroxyl substituents: A density functional theory study

    Mona Rahimi, Alireza Fattahi

    Мақола20202 иқтибос
    ABI

  22. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases

    Devon E. McMahon, Erin Amerson, Misha Rosenbach +11

    Мақола20212 иқтибос
    ABI

  23. Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report

    Luca Spiro Santovito, Graziano Pinna

    Бошқа20212 иқтибос
    ABI

  24. Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions

    Marisa McGinley, Jeffrey A. Cohen

    Шарҳ мақола20212 иқтибос
    ABI

  25. The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

    Sonia Ndeupen, Zhen Qin, Sonya Jacobsen +3

    Мақола20212 иқтибос
    ABI